Tempest Therapeutics TPST
NASDAQ TPST
$0.81 -0.03 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Receivables - Other (2021 - 2022)

Updated

Tempest Therapeutics (TPST) posted Receivables - Other of $450,000 for Q4 2022, down 97.0% from $15 million a year earlier.

Analysis

Tempest Therapeutics (TPST) Receivables - Other (2021 - 2022) Analysis & Trends

  • In prior years, Tempest Therapeutics' Receivables - Other was $15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tempest Therapeutics 4.09 Mn -26.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 450,000.00
Dec 31, 2021 15.00 Mn
API Access

Tempest Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TPST&period=max&api_key=YOUR_API_KEY